ThermoGenesis Announces Approval of AXP by India Ministry of Health
ThermoGenesis Corp. (NASDAQ: KOOL) said today that India's Ministry of Health has approved the AutoXpress® System, enabling the Company to initiate commercial sales of the product in India. The AXP is used for the processing of stem cells from cord blood.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.